The secret of FOXP3 downregulation in the inflammation condition

International Journal of Clinical and Experimental Pathology

Volumn 5, Issue 7, 2012, Pages 624-625

  Li, Yang ^a   Zheng, Song Guo ^a,b  

^a Key Laboratory of Arrhythmias of Ministry of Education   (China)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA;

DRUG EFFECT; HUMAN; METABOLISM; NOTE; SIGNAL TRANSDUCTION;

FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKIN-6; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84866037961     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Note

References (15)

1. Fontenot JD, Gavin MA and Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003; 4: 330-336.
2. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, Kelly TE, Saulsbury FT, Chance PF and Ochs HD. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001; 27: 20-21.
3. Sakaguchi S, Sakaguchi N, Asano M, Itoh M and Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151-1164.
4. Zheng SG, Gray JD, Ohtsuka K, Yamagiwa S and Horwitz DA. Generation ex vivo of TGFbeta-producing regulatory T cells from CD4+CD25- precursors. J Immunol 2002; 169: 4183-4189.
5. Lan Q, Fan H, Quesniaux V, Ryffel B, Liu Z and Guo Zheng S. Induced Foxp3+ regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases? J Mol Cell Biol 2012; 4: 22-28.
6. Tran DQ. TGF-beta: the sword, the wand, and the shield of FOXP3(+) regulatory T cells. J Mol Cell Biol 2012; 4: 29-37.
7. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL and Kuchroo VK. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441: 235-238.
8. Zhou X, Wang J, Shi W, Brand DD, Liu Z, Fan H and Zheng SG. Isolation of purified and live Foxp3+ regulatory T cells using FACS sorting on scatter plot. J Mol Cell Biol 2010; 2: 164-169.
9. Gao Z, Gao Y, Li Z, Chen Z, Lu D, Tsun A, Li B. Synergy between IL-6 and TGF-β signaling can promote FOXP3 degradation. Int J Clin Exp Pathol 2012; 5: 626-633.
10. Zheng SG, Wang J, Wang P, Gray JD and Horwitz DA. IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J Immunol 2007; 178: 2018-2027.
11. Xu L, Kitani A, Fuss I and Strober W. Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGFbeta. J Immunol 2007; 178: 6725-6729.
12. Zheng SG, Wang J and Horwitz DA. Cutting edge: Foxp3+CD4+CD25+ regulatory T cells induced by IL-2 and TGF-beta are resistant to Th17 conversion by IL-6. J Immunol 2008; 180: 7112-7116.
13. Zhou X, Kong N, Wang J, Fan H, Zou H, Horwitz D, Brand D, Liu Z and Zheng SG. Cutting edge: all-trans retinoic acid sustains the stability and function of natural regulatory T cells in an inflammatory milieu. J Immunol 2010; 185: 2675-2679.
14. Zhou X, Bailey-Bucktrout SL, Jeker LT, Penaranda C, Martinez-Llordella M, Ashby M, Nakayama M, Rosenthal W and Bluestone JA. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol 2009; 10: 1000-1007.
15. Lu L, Wang J, Zhang F, Chai Y, Brand D, Wang X, Horwitz DA, Shi W and Zheng SG. Role of SMAD and non-SMAD signals in the development of Th17 and regulatory T cells. J Immunol 2010; 184: 4295-4306.